Therapeutic Drug Monitoring Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Therapeutic Drug Monitoring Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Summary
GlobalData's Medical Devices sector report, “Therapeutic Drug Monitoring Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Therapeutic Drug Monitoring pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Therapeutic drug monitoring tests include reagents and test kits intended to measure different types of therapeutic drugs from samples ranging from serum/blood, urine, hair and sweat.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Therapeutic Drug Monitoring under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Therapeutic Drug Monitoring and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Therapeutic Drug Monitoring under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
About GlobalData
Introduction
Therapeutic Drug Monitoring Overview
Products under Development
Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
Table Figure 1: Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
Table Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
Therapeutic Drug Monitoring - Pipeline Products by Segment
Table Figure 2: Therapeutic Drug Monitoring - Pipeline Products by Segment
Table Therapeutic Drug Monitoring - Pipeline Products by Segment
Therapeutic Drug Monitoring - Pipeline Products by Territory
Table Figure 3: Therapeutic Drug Monitoring - Pipeline Products by Territory
Table Therapeutic Drug Monitoring - Pipeline Products by Territory
Therapeutic Drug Monitoring - Pipeline Products by Regulatory Path
Table Figure 4: Therapeutic Drug Monitoring - Pipeline Products by Regulatory Path
Table Therapeutic Drug Monitoring - Pipeline Products by Regulatory Path
Therapeutic Drug Monitoring - Pipeline Products by Estimated Approval Date
Table Figure 5: Therapeutic Drug Monitoring - Pipeline Products by Estimated Approval Date
Table Therapeutic Drug Monitoring - Pipeline Products by Estimated Approval Date
Therapeutic Drug Monitoring - Ongoing Clinical Trials
Table Figure 6: Therapeutic Drug Monitoring - Ongoing Clinical Trials
Table Therapeutic Drug Monitoring - Ongoing Clinical Trials
Therapeutic Drug Monitoring - Pipeline Products under Development by Companies
Therapeutic Drug Monitoring Companies - Pipeline Products by Stage of Development
Table Therapeutic Drug Monitoring Companies - Pipeline Products by Stage of Development
Therapeutic Drug Monitoring - Companies Pipeline Products by Stage of Development
Table Therapeutic Drug Monitoring - Companies Pipeline Products by Stage of Development
Therapeutic Drug Monitoring Companies and Product Overview
Table Immunobiogram - Renal Transplantation - Longitudinal Observational Study to Determine the Correlation Between Patient's Pharmacodynamic Response to Immunosuppressants Measured in Vitro with IMMUNOBIOGRAM and of Rejection in Graft Biopsies in Patients with Renal Transplantation
Boston University Company Overview
Boston University Pipeline Products & Ongoing Clinical Trials Overview
Table Boston University Pipeline Products & Ongoing Clinical Trials Overview
Table Ex Vivo 3D Drug Response (EV3D) Assay - 3D Prediction of Patient-specific Response Using Ex Vivo Interrogation of Live Cells from Tumors: 3D-PREDICT REGISTRY
Jan 16, 2023: TheraDiag Reports 2022 Revenue of 12.2 Million, up 9.7%
Jan 08, 2023: Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2023
Dec 23, 2022: Asep Medical achieves significant milestones addressing antibiotic failure through proprietary diagnostic & therapeutic technologies
Dec 20, 2022: New blood test to identify infections could reduce global antibiotic overuse
Dec 16, 2022: HealthBeacon appoints Lar Malone as interim chief financial officer
Dec 15, 2022: Bristol Myers Squibb to Report Results for Fourth Quarter 2022 on February 2, 2023
Nov 21, 2022: Thermo Fisher Scientific to Present at Evercore ISI HealthCONx Conference
Nov 11, 2022: Olympus Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2023
Nov 11, 2022: Horiba Announces Summary of Consolidated Financial Statements for the Nine Months Ended September 30, 2022
Nov 11, 2022: Olympus Announces Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2023
Nov 09, 2022: Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2022
Nov 08, 2022: PerkinElmer Announces Financial Results for the Third Quarter of 2022
Nov 03, 2022: Adaptive Biotechnologies Reports Third Quarter 2022 Financial Results
Nov 01, 2022: Waters Corp Reports Third Quarter 2022 Financial Results
Oct 24, 2022: Cohere Health and Humana Expand Partnership to Further Improve Physician and Member Experiences
Oct 21, 2022: Olympus Announces Leadership Succession Plan
Oct 21, 2022: Olympus Corp Notice Concerning Changes of Representative Executive Officer and Management Team
Oct 13, 2022: Biomerica Reports 30% Increase in Revenues for Fiscal Q1 2023 vs. Fiscal Q1 2022
Oct 12, 2022: T2 Biosystems Announces Preliminary Third Quarter 2022 Financial Results and Updates 2022 Financial Outlook
Oct 10, 2022: Creso Pharma accelerates company strategy with two new Director appointments, board transition and rebranding strategy to unlock additional M&A opportunities
Sep 30, 2022: Theradiag: Appointment of an Independent Expert
Sep 29, 2022: Avacta Group Announces Interim Results for the Period Ended 30 June 2022
Sep 19, 2022: Theradiag Announces Its Results for the First Half of 2022: Breaking-Even and Confirming Its Ability to Be Structurally Profitable From Early 2023
Sep 14, 2022: Horiba announces Review of First Half of 2022
Sep 08, 2022: Quest Diagnostics to Speak at the Morgan Stanley 20th Annual Global Healthcare Conference
Sep 07, 2022: Amneal Appoints Gustavo Pesquin as Executive Vice President Chief Commercial Officer
Aug 31, 2022: Bristol Myers Squibb to Participate in Citi's 17th Annual BioPharma Conference
Aug 30, 2022: Biomerica Plans Launch of InFoods IBS Test; Names Robert Carlson as Chief Commercial Officer
Aug 29, 2022: SQI Diagnostics Reports Third Quarter 2022 Results
Aug 24, 2022: New line of electrochemistry bench meters simplify pH, conductivity and dissolved oxygen measurement
Aug 15, 2022: Acurx Pharmaceuticals Reports Second Quarter 2022 Results
Aug 12, 2022: Horiba announce Summary of Consolidated Financial Statements for the Six Months Ended June 30, 2022
Aug 11, 2022: Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2022
Aug 11, 2022: Precipio Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Aug 10, 2022: Olympus announces First Quarter Results
Aug 09, 2022: Olympus Corp. Announces Consolidated Financial Results for the Three Months of the Fiscal Year Ending March 31, 2023
Aug 08, 2022: Precipio Announces Second Quarter Shareholder Update Call
Aug 04, 2022: Aurinia Reports Second Quarter and Six Months 2022 Financial and Operational Results
Aug 03, 2022: Adaptive Biotechnologies Reports Second Quarter 2022 Financial Results
Aug 01, 2022: PerkinElmer Announces Financial Results for the Second Quarter of 2022